-
1.发明授权Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man 失效基于用于治疗败血症或引起炎症反应的攻击的氨基酸的组合物，在动物和人中
公开(公告)号：US5863906A
公开(公告)日：1999-01-26
申请号：US896611
申请日：1997-07-18
申请人： Maurice Arnal , Francis Rose , Denis Breuille , Christiane Obled
发明人： Maurice Arnal , Francis Rose , Denis Breuille , Christiane Obled
IPC分类号： A61K9/08 , A01N43/04 , A23L1/305 , A61K9/14 , A61K31/195 , A61K31/198 , A61K31/425 , A61K31/70 , A61K38/00 , A61P31/04
CPC分类号： A61K31/198 , A23L33/175 , A23L33/40 , A23V2002/00
摘要： Compositions and methods intended to be administered enterally or parenterally for treating sepsis. The composition containing, in a biologically and nutritionally acceptable medium, at least free cysteine or cysteine in the form of a precursor, prodrug, protein or peptide hydrolysate, in a proportion of pharmacologically active cysteine greater than the proportion of cysteine present in a nutritional composition corresponding to the requirements of a healthy man, the proportion of cysteine being determined with respect to all the amino acids present in the composition.
摘要翻译： 用于肠道或胃肠外用于治疗败血症的组合物和方法。 所述组合物在生物和营养上可接受的培养基中至少含有前体，前药，蛋白质或肽水解产物形式的游离半胱氨酸或半胱氨酸，其比例大于存在于营养组合物中的半胱氨酸的比例的药理活性半胱氨酸 对应于健康人的要求，相对于组合物中存在的所有氨基酸确定半胱氨酸的比例。
-
2.发明授权Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction in animals and man 失效基于用于治疗败血症的氨基酸或在动物和人中引起炎症反应的攻击的组合物
公开(公告)号：US5756481A
公开(公告)日：1998-05-26
申请号：US647124
申请日：1996-05-09
申请人： Maurice Arnal , Francis Rose , Denis Breuille , Christiane Obled
发明人： Maurice Arnal , Francis Rose , Denis Breuille , Christiane Obled
IPC分类号： A61K9/08 , A01N43/04 , A23L1/305 , A61K9/14 , A61K31/195 , A61K31/198 , A61K31/425 , A61K31/70 , A61K38/00 , A61P31/04
CPC分类号： A61K31/198 , A23L33/175 , A23L33/40 , A23V2002/00
摘要： Compositions and methods intended to be administered enterally or parenterally for treating sepsis. The composition containing, in a biologically and nutritionally acceptable medium, at least free cysteine or cysteine in the form of a precursor, prodrug, protein or peptide hydrolysate, in a proportion of pharmacologically active cysteine greater than the proportion of cysteine present in a nutritional composition corresponding to the requirements of a healthy man, the proportion of cysteine being determined with respect to all the amino acids present in the composition.
摘要翻译： 用于肠道或胃肠外用于治疗败血症的组合物和方法。 所述组合物在生物和营养上可接受的培养基中至少含有前体，前药，蛋白质或肽水解产物形式的游离半胱氨酸或半胱氨酸，其比例大于存在于营养组合物中的半胱氨酸的比例的药理活性半胱氨酸 对应于健康人的要求，相对于组合物中存在的所有氨基酸确定半胱氨酸的比例。
-
搜索结果
2 条记录 (耗时 0.009 秒)
